Y Intercept Hong Kong Ltd Buys New Holdings in Cardinal Health, Inc. $CAH

Y Intercept Hong Kong Ltd purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 3,522 shares of the company’s stock, valued at approximately $744,000.

Other large investors have also bought and sold shares of the company. Nordea Investment Management AB grew its holdings in Cardinal Health by 328.3% in the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after acquiring an additional 494,731 shares during the last quarter. Procyon Advisors LLC increased its position in shares of Cardinal Health by 78.7% in the fourth quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock valued at $3,499,000 after acquiring an additional 7,499 shares during the period. Kornitzer Capital Management Inc. KS raised its stake in shares of Cardinal Health by 100.8% during the fourth quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company’s stock valued at $3,733,000 after acquiring an additional 9,120 shares during the last quarter. Bank of Nova Scotia raised its stake in shares of Cardinal Health by 137.4% during the third quarter. Bank of Nova Scotia now owns 393,474 shares of the company’s stock valued at $61,760,000 after acquiring an additional 227,716 shares during the last quarter. Finally, Swiss Life Asset Management Ltd boosted its holdings in shares of Cardinal Health by 73.3% during the third quarter. Swiss Life Asset Management Ltd now owns 76,736 shares of the company’s stock worth $12,044,000 after purchasing an additional 32,464 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Trading Down 0.1%

Shares of CAH stock opened at $235.54 on Monday. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $243.21. The stock has a market cap of $55.16 billion, a PE ratio of 36.01, a price-to-earnings-growth ratio of 1.16 and a beta of 0.49. The company’s fifty day moving average price is $212.35 and its 200-day moving average price is $213.05.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 10.77 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is currently 31.50%.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on CAH. William Blair started coverage on Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Morgan Stanley upped their price target on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research report on Tuesday, April 28th. Citigroup reiterated a “buy” rating on shares of Cardinal Health in a report on Thursday, July 2nd. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. Finally, Robert W. Baird set a $248.00 target price on Cardinal Health in a research note on Friday, May 1st. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $249.13.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.